Related Experiment Video
Updated: Sep 27, 2025

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
The friend within? The implantable cardioverter defibrillator between saving lives and chronically impairing them
1Department of Experimental and Clinical Medicine, University of Florence, Firenze, Italy.
Insights
Implantable cardioverter defibrillators (ICDs) manage cardiac risks but create ongoing challenges for patients. Living with an ICD involves navigating device limitations and societal expectations, impacting quality of life and identity.
Area of Science:
- Medical Sociology
- Cardiology
- Bioethics
Background:
- Biomedicine often overlooks patient lived experiences with chronic conditions.
- Technological advancements like implantable cardioverter defibrillators (ICDs) are framed as victories over acute disease.
- Chronic illness management requires understanding the patient's perspective beyond life expectancy.
Purpose of the Study:
- To explore how implantable cardioverter defibrillators (ICDs) shape the chronicity of cardiac disease.
- To investigate the patient experience of living with an embodied technology.
- To examine the interplay of risk, quality of life, and choice for patients with ICDs.
Main Methods:
- Participant observation in a clinical setting.
- Interviews with clinicians.
- Analysis of patient experiences with cardiac disease and ICDs.
Main Results:
- Patients face a continuous tension managing acute cardiac risk and daily life disruptions from the ICD.
- The concept of 'patient choice' and a 'technological imperative' to avoid risk limit patients' coping strategies.
- Living with an ICD involves a complex process of identifying with the disease and the implanted technology.
Conclusions:
- The focus on technological solutions and risk avoidance in cardiac care can inadvertently limit patients' ability to adapt to chronic illness.
- Rethinking patient autonomy and the 'technological imperative' is crucial for improving the quality of life for individuals with ICDs.
- Embodied technology significantly influences the experience and management of chronic cardiac conditions.
Abstract:
This article considers the way in which a medical technology, the implantable cardioverter defibrillator (ICD), by preventing fatal outcomes, in this case sudden death, deriving from cardiac diseases, and specifically hypertrophic cardiomyopathy, contributes to the development of a particular type of chronicity. While biomedicine celebrates technological advances in treatments and naturalises chronicity, focussing on life expectancy as a victory over the 'acute' aspects of the disease, the way in which patients live with the disease is left unquestioned. The article follows Smith-Morris's (2010) perspective in seeing chronicity as the never-ending process of identifying with one's disease, adding a focus on the role played by an embodied technology in relation to it. Based on participant observation in a clinical setting and interviews with clinicians, the article interrogates three key themes in the chronicity of cardiac patients implanted with an ICD: risk, quality of life and choice. The data shows a constant tension between managing a one-off potentially fatal 'acute' risk and life with serious disruptions due to the limitations imposed by the implanted device. The article argues that patients' resources for facing the life and identity disrupted by the disease are limited by ideas of what living a diseased body is, which acritically follow discourses of 'patient choice' and a 'technological imperative' to avoid risk.
More Related Videos
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiopulmonary Resuscitation III: AED Use
Dysrhythmias VI: Management of Dysrhythmias
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure Drugs: Inotropic Agents

